The Web Is At A Crossroads – New Standard Enables Copyright Enforcement Violating Users’ Rights 13/04/2017 by Intellectual Property Watch 5 Comments Parminder Jeet Singh writes: The World Wide Web today stands at a crossroads, as its standards body, the World Wide Web Consortium (W3C), considers the demand of big content providers to provide them with the facility to be able to control user devices for ensuring that their content is not copied. This facility is called the Encrypted Media Extension (EME), which enables these companies to put digital rights management (DRM) into the user’s browser, whether the user wants it or not, and whether such restrictions are as per the user’s local national laws or not.
The Deepening Debate Over Vaccines And Antimicrobial Resistance Involves IP 12/04/2017 by Tatum Anderson for Intellectual Property Watch 1 Comment With the looming threat of antimicrobial resistance (AMR), there is growing pressure to use vaccines because they obviate the need to prescribe antibiotics in the first place.
Hiring Freeze At USPTO Concerns Industry Groups 11/04/2017 by Intellectual Property Watch 3 Comments Members of the United States innovator business community have delivered a letter to President Trump requesting that the US Patent and Trademark Office be exempt from the federal hiring freeze announced in January.
G20 IT Ministers Want Access For All, Commit To Conflicting Objectives 07/04/2017 by Monika Ermert for Intellectual Property Watch 2 Comments The Group of 20 (G20) ministers responsible for the digital economy today called for further efforts to advance access to the internet for everyone and close the digital gaps that still exist. Gathered in Dusseldorf, Germany, for the two-day IT related preparatory conference for the G20 Summit in Hamburg in July, the ministers signed a declaration on “Shaping the Digitalisation for an Interconnected World.” It was the first time that ministers for digital economy met in the G20 format.
New Large-Scale Initiative Aims To Increase Open Access To Scholarly Research 06/04/2017 by Intellectual Property Watch 2 Comments The Wikimedia Foundation, Public Library of Science (PLoS), and other publishers and research organisations have announced an initiative aimed at increase the amount of scholarly citation data freely available online, called the Initiative for Open Citations.
Public-Private Coalition’s High-Profile Delinkage Policy For Emerging Vaccines 04/04/2017 by Tatum Anderson for Intellectual Property Watch 1 Comment It’s early February in Tchaourou district, Borgou in Benin, and a pregnant woman is admitted to hospital. Her premature baby is born by caesarean section but she dies a day later on February 12th. It turns out she had Lassa fever, a deadly viral haemorrhagic disease. But that’s only discovered after the baby is discharged from hospital and taken to northern Togo. The newborn also becomes ill and is taken to hospital for treatment.
The Current And Future Scope Of IPR Estoppel 04/04/2017 by Intellectual Property Watch Leave a Comment David I. Berl and Christopher A. Suarez write: The estoppel provision of the America Invents Act, 35 U.S.C. 315(e), was touted originally as a check against patent challengers using inter partes review (“IPR”) proceedings to attack patents serially on the same or similar grounds. That provision precludes an IPR petitioner, or the real party in interest or privy of the petitioner, from asserting invalidity challenges in subsequent IPR, district court, or International Trade Commission (“ITC”) proceedings “on any ground that the petitioner raised or reasonably could have raised during” an IPR that resulted “in a final written decision.” Given the frequency of IPR and associated district court challenges, the scope of the AIA’s estoppel provision, with respect to the parties and arguments it estops, has become and will continue to be a critical and frequently contested issue for litigants.
Report Finds Wide Gap In Pharma Companies’ Profits And Spending On R&D 03/04/2017 by Intellectual Property Watch 2 Comments A new report from Public Citizen, the US-based consumer rights advocacy group, shows that the 20 largest pharmaceutical corporations are spending significantly less on research and development of new medicines than they are making in profits.
Special Report: Will The Internet Of Things Need New Patenting/Licensing Strategies? 03/04/2017 by Dugie Standeford for Intellectual Property Watch Leave a Comment The Internet of Things (IoT), which will connect billions of devices in coming years, may offer incredible opportunities for businesses and consumers but it also raises significant intellectual property issues, IP lawyers, mobile operators and others say. One key question is whether patenting and licensing strategies will have to change to adapt to the myriad standards being developed and patents being sought for IoT products and services, and for the coming rollout of 5G technologies.
Report: Market Share Of Orphan Drugs Could Top 20 Percent Of Global Market By 2022 03/04/2017 by Intellectual Property Watch Leave a Comment A new industry report shows that the average prices for orphan drugs are increasing and are projected to comprise more than 20 percent of the patented pharmaceutical sales market by 2022.